Anouk E. Muller

3.3k total citations
75 papers, 2.1k citations indexed

About

Anouk E. Muller is a scholar working on Pharmacology, Epidemiology and Molecular Medicine. According to data from OpenAlex, Anouk E. Muller has authored 75 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pharmacology, 45 papers in Epidemiology and 30 papers in Molecular Medicine. Recurrent topics in Anouk E. Muller's work include Antibiotics Pharmacokinetics and Efficacy (51 papers), Antibiotic Resistance in Bacteria (30 papers) and Pneumonia and Respiratory Infections (29 papers). Anouk E. Muller is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (51 papers), Antibiotic Resistance in Bacteria (30 papers) and Pneumonia and Respiratory Infections (29 papers). Anouk E. Muller collaborates with scholars based in Netherlands, Switzerland and Belgium. Anouk E. Muller's co-authors include Johan W. Mouton, Angela Huttner, Birgit C. P. Koch, Nieko Punt, Ursula Theuretzbacher, Stephan Harbarth, Alan Abdulla, Rafael Cantón, Gunnar Kahlmeter and John Turnidge and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, American Journal of Obstetrics and Gynecology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Anouk E. Muller

72 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anouk E. Muller Netherlands	24	1.0k	935	617	362	291	75	2.1k
Angela Huttner Switzerland	28	810 0.8×	1.2k 1.3×	611 1.0×	534 1.5×	404 1.4×	101	2.9k
Ayman Noreddin United States	25	1.0k 1.0×	984 1.1×	1.1k 1.8×	315 0.9×	240 0.8×	73	2.9k
Sebastian G. Wicha Germany	23	1.5k 1.4×	719 0.8×	472 0.8×	278 0.8×	320 1.1×	118	2.3k
Kazuro Ikawa Japan	23	1.2k 1.2×	735 0.8×	526 0.9×	261 0.7×	206 0.7×	127	1.9k
Giannoula S. Tansarli United States	24	828 0.8×	1.0k 1.1×	1.4k 2.3×	674 1.9×	422 1.5×	50	2.5k
Sandra L. Preston United States	25	1.1k 1.1×	941 1.0×	676 1.1×	212 0.6×	214 0.7×	45	2.4k
Christopher M. Rubino United States	24	1.3k 1.3×	808 0.9×	807 1.3×	264 0.7×	350 1.2×	112	2.2k
Joseph A. Paladino United States	25	1.2k 1.1×	965 1.0×	581 0.9×	683 1.9×	392 1.3×	78	2.3k
Michael Postelnick United States	26	754 0.7×	486 0.5×	406 0.7×	517 1.4×	498 1.7×	88	2.3k
Olaf Burkhardt Germany	27	728 0.7×	1.0k 1.1×	390 0.6×	266 0.7×	221 0.8×	56	2.1k

Countries citing papers authored by Anouk E. Muller

Since Specialization

Citations

This map shows the geographic impact of Anouk E. Muller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anouk E. Muller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anouk E. Muller more than expected).

Fields of papers citing papers by Anouk E. Muller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anouk E. Muller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anouk E. Muller. The network helps show where Anouk E. Muller may publish in the future.

Co-authorship network of co-authors of Anouk E. Muller

This figure shows the co-authorship network connecting the top 25 collaborators of Anouk E. Muller. A scholar is included among the top collaborators of Anouk E. Muller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anouk E. Muller. Anouk E. Muller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berg, Sanne van den, Marie Attwood, Anouk E. Muller, et al.. (2025). Pharmacodynamics of NOSO-502 studied in vitro and in vivo: determination of the dominant pharmacodynamic index driver. Journal of Antimicrobial Chemotherapy. 80(3). 752–759. 2 indexed citations

Berg, Sanne van den, William Couet, Sandrine Marchand, et al.. (2025). The synergistic effect of the combination of polymyxin B and rifampicin in a murine neutropenic thigh infection model with E. coli and K. pneumoniae. Journal of Antimicrobial Chemotherapy. 80(5). 1248–1255. 2 indexed citations

Zhao, Chenyan, Sanne van den Berg, Zhigang Wang, et al.. (2025). An integrative and translational PK/PD modelling approach to explore the combined effect of polymyxin B and minocycline against Klebsiella pneumoniae. International Journal of Antimicrobial Agents. 65(3). 107443–107443.

Muller, Anouk E., et al.. (2024). Dose Individualisation of Antimicrobials from a Pharmacometric Standpoint: The Current Landscape. Drugs. 84(10). 1167–1178. 2 indexed citations

Keij, Fleur M., Gerdien A. Tramper‐Stranders, René F. Kornelisse, et al.. (2024). A Pooled Population Pharmacokinetic Study of Oral and Intravenous Administration of Clavulanic Acid in Neonates and Infants: Targeting Effective Beta‐Lactamase Inhibition. Clinical Pharmacology & Therapeutics. 117(1). 193–202. 2 indexed citations

Muller, Anouk E., Peter Van de Vliet, & Birgit C. P. Koch. (2023). Clinical Experience with Off-Label Intrathecal Administration of Selected Antibiotics in Adults: An Overview with Pharmacometric Considerations. Antibiotics. 12(8). 1291–1291. 3 indexed citations

Koch, Birgit C. P., et al.. (2023). Population plasma and urine pharmacokinetics and the probability of target attainment of fosfomycin in healthy male volunteers. European Journal of Clinical Pharmacology. 79(6). 775–787. 6 indexed citations

Ewoldt, Tim M. J., Alan Abdulla, Nicole Hunfeld, et al.. (2023). Meropenem Model-Informed Precision Dosing in the Treatment of Critically Ill Patients: Can We Use It?. Antibiotics. 12(2). 383–383. 10 indexed citations

Meletiadis, Joseph, et al.. (2023). In Vitro–In Vivo Correlation of Posaconazole–Amphotericin B Combination against Candida albicans: In Vitro Interacting Concentrations Are Associated with In Vivo Free Drug Levels. Journal of Fungi. 9(4). 434–434. 3 indexed citations

10.

Muller, Anouk E., et al.. (2022). An Overview of the Protein Binding of Cephalosporins in Human Body Fluids: A Systematic Review. Frontiers in Pharmacology. 13. 900551–900551. 18 indexed citations

11.

Doesschate, Thijs ten, Tamara N Platteel, Anouk E. Muller, et al.. (2021). Nitrofurantoin 100 mg versus 50 mg prophylaxis for urinary tract infections, a cohort study. Clinical Microbiology and Infection. 28(2). 248–254. 7 indexed citations

12.

Allegaert, Karel, Anouk E. Muller, Francesca Maria Russo, et al.. (2020). Pregnancy‐related pharmacokinetics and antimicrobial prophylaxis during fetal surgery, cefazolin and clindamycin as examples. Prenatal Diagnosis. 40(9). 1178–1184. 6 indexed citations

13.

Wijma, Rixt A., Angela Huttner, Wendy Kloezen, et al.. (2019). Urinary antibacterial activity of fosfomycin and nitrofurantoin at registered dosages in healthy volunteers. International Journal of Antimicrobial Agents. 54(4). 435–441. 5 indexed citations

14.

Huttner, Angela, Rixt A. Wijma, Andrew J. Stewardson, et al.. (2019). The pharmacokinetics of nitrofurantoin in healthy female volunteers: a randomized crossover study. Journal of Antimicrobial Chemotherapy. 74(6). 1656–1661. 19 indexed citations

15.

Muller, Anouk E., Benedikt Huttner, & Angela Huttner. (2018). Therapeutic Drug Monitoring of Beta-Lactams and Other Antibiotics in the Intensive Care Unit: Which Agents, Which Patients and Which Infections?. Drugs. 78(4). 439–451. 90 indexed citations

16.

Dautzenberg, Mirjam J. D., Jumamurat R. Bayjanov, Maurine A. Leverstein‐van Hall, et al.. (2018). Dynamics of colistin and tobramycin resistance among Enterobacter cloacae during prolonged use of selective decontamination of the digestive tract. Antimicrobial Resistance and Infection Control. 7(1). 67–67. 4 indexed citations

17.

Muller, Anouk E., et al.. (2016). Nitrofurantoin's efficacy and safety as prophylaxis for urinary tract infections: a systematic review of the literature and meta-analysis of controlled trials. Clinical Microbiology and Infection. 23(6). 355–362. 51 indexed citations

18.

Muller, Anouk E., Ursula Theuretzbacher, & Johan W. Mouton. (2015). Use of old antibiotics now and in the future from a pharmacokinetic/pharmacodynamic perspective. Clinical Microbiology and Infection. 21(10). 881–885. 38 indexed citations

19.

Muller, Anouk E., P. Joep Dörr, Johan W. Mouton, et al.. (2008). The influence of labour on the pharmacokinetics of intravenously administered amoxicillin in pregnant women. British Journal of Clinical Pharmacology. 66(6). 866–874. 15 indexed citations

20.

Muller, Anouk E., Joost DeJongh, Paul M. Oostvogel, et al.. (2007). Amoxicillin pharmacokinetics in pregnant women with preterm premature rupture of the membranes. American Journal of Obstetrics and Gynecology. 198(1). 108.e1–108.e6. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact